or Try an Advanced Search...

    Tyrosine Kinase Inhibitors Stocks List

    Symbol Grade Name % Change
    VTVT C vTv Therapeutics Inc. 2.08
    RIGL D Rigel Pharmaceuticals, Inc. -16.61
    EXEL D Exelixis, Inc. -2.53
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Autoimmune Disease Cancer Daiichi Sankyo Tyrosine Kinase Tyrosine Kinases Adenosine Alzheimer's Disease Asthma Biopharmaceutical Biotechnology Biotie Therapies Buparlisib Cancer Cell Chemical Compounds Chronic Obstructive Pulmonary Disease Cyclopropanes Diabetes Discoid Lupus Disease Drug Development

    Related ETFs - A few ETFs which own one or more of the above listed Tyrosine Kinase Inhibitors stocks.

    Symbol Grade Name Weight
    IDNA C iShares Genomics Immunology and Healthcare ETF 3.55
    FBT D First Trust Amex Biotech Index Fund 3.21
    PBE C PowerShares Dynamic Biotech & Genome 2.94
    LABD D Direxion Daily S&P Biotech Bear 3X Shares 1.91
    BBP D BioShares Biotechnology Products Fund 1.88
    View all Tyrosine Kinase Inhibitors ETFs...
    Compare ETFs
    Compare FBT to BBP Compare IDNA to BBP Compare IDNA to LABD

        Tyrosine Kinase Inhibitors Stocks Recent News

        Date Stock Title
        May 7 EXEL Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May
        May 6 EXEL Exelixis (EXEL) International Revenue Performance Explored
        May 2 EXEL Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript
        May 2 EXEL Exelixis: With Patent Litigation Decision Due Soon, There Are Options
        May 2 RIGL ProPhase Labs, Inc. (PRPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
        May 2 EXEL Exelixis, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
        Related Industries: Biotechnology
        Related Stock Lists: Autoimmune Disease Cancer Daiichi Sankyo Tyrosine Kinase Tyrosine Kinases Adenosine Alzheimer's Disease Asthma Biopharmaceutical Biotechnology Biotie Therapies Buparlisib Cancer Cell Chemical Compounds Chronic Obstructive Pulmonary Disease Cyclopropanes Diabetes Discoid Lupus Disease Drug Development
        Tyrosine Kinase Inhibitors

        Tyrosine Kinase Inhibitors (TKIs) are a type of targeted therapy used to treat cancer. They work by blocking the activity of certain proteins called tyrosine kinases, which are involved in the growth and spread of cancer cells. TKIs are used to treat a variety of cancers, including chronic myeloid leukemia, non-small cell lung cancer, and gastrointestinal stromal tumors.

        Browse All Tags